Article

Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.

2024-01-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> The study aimed to validate the Betella algorithm, focusing on molecular analyses exclusively for endometrial cancer patients, where molecular classification alters risk assessment based on ESGO/ESTRO/ESP 2020 guidelines. <bold>Methods</bold> Conducted between March 2021 and March 2023, the retrospective research involved endometrial cancer patients undergoing su...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c0cc7642-b257-531d-9286-4496229f7ac7
DOI: 10.21203/rs.3.rs-3839781/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.DOI 10.21203/rs.3.rs-3839781/v1Read

Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.Semantic proximity Read

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerSemantic proximity Read

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read

Interpretation strategy of POLE, mismatch repair deficiency, and p53 in the multiple molecular classification of endometrial carcinoma and its clinical differences from single classification: a retrospective cohort study.Semantic proximity Read

FIGO 2023 Staging and Molecular Classification of 172 patients with Endometrial CancerSemantic proximity Read

FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in 172 endometrial cancer patients.Semantic proximity Read

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read

[The influence of molecular classification in the selection of postoperative adjuvant therapy in endometrial carcinoma].Semantic proximity Read

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read

Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomasSemantic proximity Read